[Proceedings: Current status and perspectives of tuberculosis chemotherapy in Algeria].
D000462:Algeria; D000553:Ambulatory Care; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013997:Time Factors; D014376:Tuberculosis / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007538:Isoniazid; D013307:Streptomycin
Gegenwärtiger Stand und die Perspektiven der Chemotherapie der Tuberkulose in Algerien.